Drugs / Mono Nuclear Cell (MNC)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02256501 | Jun 2013 → Mar 2016 | cardiomyopathy | Nasser Aghdami MD., PhD | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mono Nuclear Cell (MNC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02256501 ↗ |